Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Department

News Connection
Over $1.4 Billion Wasted on Discarded Cancer Drugs According to Medicare Advantage, CMS Data
09/25/2020
According to a recent data analysis by the Centers for Medicare & Medicaid Services (CMS) and Medicare Advantage, more than $1.4 billion was wasted on discarded units of chemotherapy and other cancer-treating drugs in 2017 and 2018.
According to a recent data analysis by the Centers for Medicare & Medicaid Services (CMS) and Medicare Advantage, more than $1.4 billion was wasted on discarded units of chemotherapy and other cancer-treating drugs in 2017 and 2018.
According to a recent data...
09/25/2020
First Report Managed Care
News Connection
CMS Launches Digital Medicare Platform, Streamlines Resources
09/25/2020
Care Compare, a redesign of eight existing health care tools and platforms, was launched by the Centers of Medicare & Medicaid Services (CMS) recently in an effort to improve patient access to information and streamline health care service...
Care Compare, a redesign of eight existing health care tools and platforms, was launched by the Centers of Medicare & Medicaid Services (CMS) recently in an effort to improve patient access to information and streamline health care service...
Care Compare, a redesign of...
09/25/2020
First Report Managed Care

Advertisement

News Connection
CMS Unveils New Model to Improve Rural Health Care
09/25/2020
President Trump signed an executive order recently dedicated to improving rural health care systems through the implementation of the newly unveiled Community Health Access and Rural Transformation (CHART) model, which will be fund...
President Trump signed an executive order recently dedicated to improving rural health care systems through the implementation of the newly unveiled Community Health Access and Rural Transformation (CHART) model, which will be fund...
President Trump signed an...
09/25/2020
First Report Managed Care
Conference Insider
Examining Disease Modifying Therapy Utilization Rates in Patients With MS
09/23/2020
“Since early initiation of disease modifying therapy has been associated with improved outcome [in MS patients], this phenomenon deserves further investigation,” explained researchers of a recent study.
“Since early initiation of disease modifying therapy has been associated with improved outcome [in MS patients], this phenomenon deserves further investigation,” explained researchers of a recent study.
“Since early initiation of...
09/23/2020
First Report Managed Care
Conference Insider
Safety of Ofatumumab Remains Consistent for Relapsing MS Treatment
09/23/2020
Researchers recently presented long-term data assessing the safety and benefit-risk profile of ofatumumab for the treatment of relapsing multiple sclerosis.
Researchers recently presented long-term data assessing the safety and benefit-risk profile of ofatumumab for the treatment of relapsing multiple sclerosis.
Researchers recently presented...
09/23/2020
First Report Managed Care

Advertisement

Conference Insider
Understanding Costs of Infusion Disease-Modifying Drugs for Treatment of Multiple Sclerosis
09/23/2020
“Costs associated with administering infusion DMDs among patients with MS in the US should be considered in economic analyses,” said researchers of a recent study.
“Costs associated with administering infusion DMDs among patients with MS in the US should be considered in economic analyses,” said researchers of a recent study.
“Costs associated with...
09/23/2020
First Report Managed Care
Formulary Frontlines®
Migraine and Payer Management Challenges
08/31/2020

Edan Stanley

Edan Stanley
Headache is extremely common in the general population, but despite its high prevalence and impairment, migraine is often not recognized or effectively treated. Because new classes of drugs and nondrug treatments continue to surface, more...
Headache is extremely common in the general population, but despite its high prevalence and impairment, migraine is often not recognized or effectively treated. Because new classes of drugs and nondrug treatments continue to surface, more...
Headache is extremely common in...
08/31/2020
First Report Managed Care
Veterans Health Today
Recognizing Causes of Alcohol Use Disorder
08/31/2020
Lifetime drug use disorder, greater alcohol use at baseline, and trauma-related characteristics were independently associated with developing alcohol use disorder within 7 years of follow-up in US military veterans, according to a study...
Lifetime drug use disorder, greater alcohol use at baseline, and trauma-related characteristics were independently associated with developing alcohol use disorder within 7 years of follow-up in US military veterans, according to a study...
Lifetime drug use disorder,...
08/31/2020
First Report Managed Care

Advertisement

Veterans Health Today
To Reduce Suicide Risk in Veterans, Efforts Must Include Functioning, Well-being
08/31/2020
Mental health services to reduce suicide risk among US veterans should focus on maintaining or improving basic functioning (living, financial, and vocational) and well-being (social, psychological, and spiritual), suggests findings from a...
Mental health services to reduce suicide risk among US veterans should focus on maintaining or improving basic functioning (living, financial, and vocational) and well-being (social, psychological, and spiritual), suggests findings from a...
Mental health services to reduce...
08/31/2020
First Report Managed Care
Veterans Health Today
Group-Based Integrative Health Program Improves Mental Health, Pain in Female Veterans
08/31/2020
Participation in a group-based complementary and integrative health program significantly improved self-reported mental health and pain interfering with work in a pilot sample of female veterans, according to a study published in Explore. 
Participation in a group-based complementary and integrative health program significantly improved self-reported mental health and pain interfering with work in a pilot sample of female veterans, according to a study published in Explore. 
Participation in a group-based...
08/31/2020
First Report Managed Care

Advertisement

Advertisement

Advertisement

FRMC Volume 21, Issue 3

Current Issue

September 2024
Volume 21
Issue 3
Current Issue
Issue Archive

Advertisement

Advertisement

What's Trending?

News
COVID-19 Vaccination Does Not Increase Relapse Risk in Patients With Multiple Sclerosis
09/19/2024
COVID-19 vaccination does not increase the risk of severe relapse for most patients with multiple sclerosis (MS), according to study results published in the American Journal of Neurology.
COVID-19 vaccination does not increase the risk of severe relapse for most patients with multiple sclerosis (MS), according to study results published in the American Journal of Neurology.
COVID-19 vaccination does not...
09/19/2024
First Report Managed Care
News
Identifying Large-Vessel Vasculitis in Polymyalgia Rheumatica: Key Clinical and Laboratory Red Flags
04/05/2024
Lisa Kuhns, PhD
Potential red flags for large-vessel vasculitis in isolated polymyalgia rheumatica (PMR) include inflammatory back pain, significant pelvic involvement, widespread lower extremity pain, marked inflammatory response indicated by specific lab...
Potential red flags for large-vessel vasculitis in isolated polymyalgia rheumatica (PMR) include inflammatory back pain, significant pelvic involvement, widespread lower extremity pain, marked inflammatory response indicated by specific lab...
Potential red flags for...
04/05/2024
First Report Managed Care
Literature Review
Comparing IL-6 Inhibitors and Glucocorticoids in Treating PMR: SAPHYR Trial Results
10/16/2023

Danielle Sposato

Danielle Sposato
The SAPHYR trial has provided researchers with valuable insights into alternative treatment options for PMR due to its larger patient population. The effectiveness of sarilumab and the achieved rates of remission offer promise for enhancing...
The SAPHYR trial has provided researchers with valuable insights into alternative treatment options for PMR due to its larger patient population. The effectiveness of sarilumab and the achieved rates of remission offer promise for enhancing...
The SAPHYR trial has provided...
10/16/2023
First Report Managed Care
Conference Coverage
SOHO 2024 Insights: Examining the Use and Cost of Interferon Therapy for MPNs
09/13/2024
In this interview, a leading expert discusses myeloproliferative neoplasms, as presented at the SOHO annual conference. Explore the interview to gain key insights into interferon therapies and important considerations for payers regarding...
In this interview, a leading expert discusses myeloproliferative neoplasms, as presented at the SOHO annual conference. Explore the interview to gain key insights into interferon therapies and important considerations for payers regarding...
In this interview, a leading...
09/13/2024
First Report Managed Care
News
Biologics: Changing the Treatment Scope for Psoriasis and Psoriatic Arthritis
12/15/2014

Eileen Koutnik-Fotopoulos

Eileen Koutnik-Fotopoulos
Biologic agents have altered the treatment landscape in the management of moderate-to-severe psoriasis and psoriatic arthritis.
Biologic agents have altered the treatment landscape in the management of moderate-to-severe psoriasis and psoriatic arthritis.
Biologic agents have altered the...
12/15/2014
First Report Managed Care

Video Insights

Title Card
Videos
Addressing the Root Cause of a Common Ocular Condition: A Virtual Roundtable
09/04/2024
View a roundtable discussion on Demodex blepharitis, a prevalent ocular condition that often goes undiagnosed in patients.
View a roundtable discussion on Demodex blepharitis, a prevalent ocular condition that often goes undiagnosed in patients.
View a roundtable discussion on...
09/04/2024
First Report Managed Care
Jordan Bazinsky
Videos
Addressing Health Disparities and Promoting Equity: The Role of Advanced Imaging Solutions
08/15/2024
Guest expert Jordan Bazinsky discusses the challenges facing the medical imaging industry, the potential of AI and emerging technologies, the role of advanced imaging solutions in promoting health equity, and the key trends and challenges...
Guest expert Jordan Bazinsky discusses the challenges facing the medical imaging industry, the potential of AI and emerging technologies, the role of advanced imaging solutions in promoting health equity, and the key trends and challenges...
Guest expert Jordan Bazinsky...
08/15/2024
First Report Managed Care
Farrukh Awan, MD
Videos
Promising Therapies and Clinical Trials for Chronic Lymphocytic Leukemia
08/14/2024
Farrukh Awan, MD, highlights promising therapies and clinical trials within the field of chronic lymphocytic leukemia (CLL).
Farrukh Awan, MD, highlights promising therapies and clinical trials within the field of chronic lymphocytic leukemia (CLL).
Farrukh Awan, MD, highlights...
08/14/2024
Journal of Clinical Pathways
Hayward
Videos
Evolving Health Care Contact Centers Into Drivers of Value-Based Care
07/31/2024
Discover how health care contact centers can transform into drivers of value-based care through AI, automation, upskilling agents, and rethinking workflows and metrics to improve patient outcomes and population health.
Discover how health care contact centers can transform into drivers of value-based care through AI, automation, upskilling agents, and rethinking workflows and metrics to improve patient outcomes and population health.
Discover how health care contact...
07/31/2024
First Report Managed Care
Lucille Accetta Headshot
Videos
Enhancing Patient Medication Adherence: Insights and Strategies From Asembia 2024
06/11/2024
Lucille Accetta, PharmD, MBA, MSPH, Senior Vice President of CVS Specialty Operations
Key stakeholders in the health care industry gathered to discuss prevalent topics at this year's Asembia annual summit. Medication adherence emerged as one of the most talked-about issues. In a session led by Lucille Accetta, PharmD, MBA,...
Key stakeholders in the health care industry gathered to discuss prevalent topics at this year's Asembia annual summit. Medication adherence emerged as one of the most talked-about issues. In a session led by Lucille Accetta, PharmD, MBA,...
Key stakeholders in the health...
06/11/2024
First Report Managed Care
Melissa Andel, Principal, CommonHealth Solutions, LLC
Videos
Navigating the Impact of the Inflation Reduction Act: Implications for Payers, Patients, and Manufacturers
05/24/2024
Melissa Andel, Principal, CommonHealth Solutions, LLC
Learn about the impacts of the Inflation Reduction Act on payers and patients, highlighting the changes in Medicare benefits and drug coverage coming in 2025 and 2026.
Learn about the impacts of the Inflation Reduction Act on payers and patients, highlighting the changes in Medicare benefits and drug coverage coming in 2025 and 2026.
Learn about the impacts of the...
05/24/2024
First Report Managed Care
Joe DePinto Headshot
Videos
Navigating Payment Models in the CGT Landscape: Insights and Innovations
05/21/2024
Joe DePinto, Head of Cell, Gene, and Advanced Therapies, McKesson
An expert discusses the evolution and challenges of payment models in the cell and gene therapy (CGT) space reviewed during his session at Asembia 2024.
An expert discusses the evolution and challenges of payment models in the cell and gene therapy (CGT) space reviewed during his session at Asembia 2024.
An expert discusses the...
05/21/2024
First Report Managed Care
Jennifer L. Mathieu Senior Vice President, Professional and Government Affairs at AMCP
Videos
Unlocking the Future of Managed Care Pharmacy: A Deep Dive into Federal Legislation and Regulations
05/15/2024
Jennifer L. Mathieu Senior Vice President, Professional and Government Affairs, AMCP
Learn about developments in federal legislation and regulations within the pharmacy landscape shaping the future of managed care in an interview with a session presenter from AMCP 2024.
Learn about developments in federal legislation and regulations within the pharmacy landscape shaping the future of managed care in an interview with a session presenter from AMCP 2024.
Learn about developments in...
05/15/2024
First Report Managed Care
Peter Martin, MD
Conference Coverage
Using Lenalidomide and Rituximab, Tazemetostat, or Bispecific Antibodies to Treat Patients With Follicular Lymphoma
04/06/2024

Featuring Peter Martin, MD

Featuring Peter Martin, MD
During the 2024 Great Debates & Updates in Hematologic Malignancies meeting in New York, Peter Martin, MD, argued in favor of alternative treatment regimens over CAR T-cell therapy for treating follicular lymphoma.
During the 2024 Great Debates & Updates in Hematologic Malignancies meeting in New York, Peter Martin, MD, argued in favor of alternative treatment regimens over CAR T-cell therapy for treating follicular lymphoma.
During the 2024 Great Debates &...
04/06/2024
Oncology
Tejaswi Kompala
Videos
Personalizing Weight Loss Management With GLP-1 Agonists
04/05/2024

Featuring Tejaswi Kompala, MD, head of cardiometabolic clinical strategy, Teladoc 

Featuring Tejaswi Kompala, MD, head o...
Delve into the rising demand for anti-obesity medications, the complexities of obesity management, and the importance of personalized approaches in improving cardiometabolic health in this insightful interview.
Delve into the rising demand for anti-obesity medications, the complexities of obesity management, and the importance of personalized approaches in improving cardiometabolic health in this insightful interview.
Delve into the rising demand for...
04/05/2024
First Report Managed Care

Subscribe to our eNewsletters!

First Report Managed Care Newsletter

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use